Compare EXEL & FIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXEL | FIVE |
|---|---|---|
| Founded | 1994 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 12.6B |
| IPO Year | 2000 | 2012 |
| Metric | EXEL | FIVE |
|---|---|---|
| Price | $52.70 | $192.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 20 |
| Target Price | $46.50 | ★ $236.00 |
| AVG Volume (30 Days) | ★ 2.4M | 1.3M |
| Earning Date | 05-05-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | 40.65 |
| EPS | 0.79 | ★ 2.21 |
| Revenue | $452,477,000.00 | ★ $4,764,147,000.00 |
| Revenue This Year | $13.61 | $14.44 |
| Revenue Next Year | $13.13 | $9.37 |
| P/E Ratio | $66.50 | ★ $29.66 |
| Revenue Growth | N/A | ★ 22.90 |
| 52 Week Low | $33.76 | $121.11 |
| 52 Week High | $52.96 | $251.63 |
| Indicator | EXEL | FIVE |
|---|---|---|
| Relative Strength Index (RSI) | 63.95 | 32.40 |
| Support Level | $40.17 | $183.64 |
| Resistance Level | N/A | $236.33 |
| Average True Range (ATR) | 1.49 | 8.21 |
| MACD | 0.07 | -2.28 |
| Stochastic Oscillator | 96.00 | 3.90 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.